Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada)

por Fischer, Benedikt, Daldegan-Bueno, Dimitri, Jones, Wayne
Publicado 2020

Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations

por Fischer, Benedikt, Daldegan‐Bueno, Dimitri, Boden, Joseph M.
Publicado 2020

Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators

por Maia, Lucas O., Daldegan-Bueno, Dimitri, Fischer, Benedikt
Publicado 2021

‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America

por Fischer, Benedikt, O’Keefe-Markman, Caroline, Lee, Angelica (Min-Hye), Daldegan-Bueno, Dimitri
Publicado 2021

Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies

por Daldegan-Bueno, Dimitri, Maia, Lucas O., Glass, Michelle, Jutras-Aswad, Didier, Fischer, Benedikt
Publicado 2021

The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand

por Fischer, Benedikt, Daldegan-Bueno, Dimitri, Bell, Ross, Boden, Joseph M., Bullen, Chris, Farrell, Michael, Hall, Wayne, Newcombe, David
Publicado 2020

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)

por Donegan, Carina Joy, Daldegan-Bueno, Dimitri, Sumner, Rachael, Menkes, David, Evans, William, Hoeh, Nicholas, Sundram, Frederick, Reynolds, Lisa, Ponton, Rhys, Cavadino, Alana, Smith, Todd, Roop, Partha, Allen, Nathan, Abeysinghe, Binu, Svirskis, Darren, Forsyth, Anna, Bansal, Mahima, Muthukumaraswamy, Suresh
Publicado 2023